At Lucid Diagnostics, we believe early detection will make esophageal cancer a disease of the past. We're using next generation sequencing to fundamentally change the way esophageal precancer is detected. Our groundbreaking EsoGuard DNA test assesses genes from cells collected from the esophagus in a quick, non-invasive procedure. This gives clinicians the ability to detect disease before it progresses to cancer, all without the need for sedation.
EsoGuard is a DNA test for detection of esophageal precancer. With over 90% sensitivity and specificity at detecting Barrett's esophagus and esophageal adenocarcinoma, the EsoGuard esophageal DNA test allows detection of these conditions in a simple office-based procedure without endoscopy.1LEARN MORE AT ESOGUARD.COM
EsoCheck with Collect+Protect™ Technology is a cell collection device that is designed to collect cells of a targeted region of the esophagus without the need for endoscopy. The sampled cells can then be subjected to any commercially available diagnostic test.LEARN MORE AT LUCIDDX.COM
Bringing EsoGuard testing to at-risk patients
Nationwide Lucid Test Centers make getting tested easy. At-risk patients can be referred to Lucid staffed test centers for the less than 5-minute esophageal cell collection.